United States· US:70518-3928_53f9bfbd-35c3-f9ac-e063-6294a90a7dcb
Prazosin hydrochloride
A prazosin product containing prazosin hydrochloride, registered in United States by REMEDYREPACK INC.. The same ATC class is registered in 9 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Prazosin is registered in 9 of 19 countries.
Countries holding a registration under ATC C02CA01 (prazosin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 4 of them publish a price we can compare per daily dose
Prazosin · ATC C02CA01
9 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- PRAZOSIN HYDROCHLORIDE
- Manufacturer
- REMEDYREPACK INC.
- Country
- United States (US)
- ATC code
- C02CA01
- ATC class
- Prazosin
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1170518-3928-0
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
98 interactions on record for prazosin.
Graded by severity as the source publishes them — 78 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Prazosin · interactions on record
98 records
- 78 moderate
- 20 info
Most severe, free to view
- ThiethylperazinA04AB03moderate
- DiphenhydraminA04AB05moderate
- DronabinolA04AD10moderate
- NabiloneA04AD11moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Prazosin in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayPrazosin Hydrochloride novitiumNovitium Pharma
- United KingdomAlphavase 1 tabletsAshbourne Pharmaceuticals Ltd
- FinlandPatsolinSchering Oy
- CanadaAPO-PRAZOAPOTEX INC
- BelgiumMinipress 1 mgPfizer
- SpainMINIPRES 1 mg COMPRIMIDOSPfizer S.L.
- FranceALPRESS L.P. 2,5 mg, comprimé osmotique à libération prolongéePFIZER HOLDING FRANCE
- IrelandHypovase 0.5mg TabletsPfizer Healthcare Ireland Unlimited Company
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Cyprus · Atodel
- Spain · Minipres
- Finland · Pratsiol
- France · Alpress L.P.
- United Kingdom (Northern Ireland) · Hypovase
- Ireland · Hypovase
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c2d2ab2e-3f65-4a13-b578-16f1be1eece0 GET /v1/drugs/c2d2ab2e-3f65-4a13-b578-16f1be1eece0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "1",
"substance": "PRAZOSIN HYDROCHLORIDE",
"productndc": "70518-3928",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA213406",
"marketing_category": "ANDA"
}See everything about prazosin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.